T helper type 2 cytokine production (Th2 cytokine production)

T helper type 2 cytokine production refers to the process by which Th2 cells, a subset of CD4+ T lymphocytes, secrete characteristic cytokines such as interleukin 4 (IL‑4), IL‑5, IL‑9, IL‑10, IL‑13, and IL‑25[1][2][3]. These cytokines are central to the activation and maintenance of humoral immune responses—particularly antibody-mediated immunity—and play key roles in defending against extracellular parasites like helminths. They also drive allergic inflammation by promoting eosinophil recruitment and IgE class-switching in B cells. Overactivation or dysregulation of Th2-type responses is implicated in various allergic diseases including asthma and atopic dermatitis[1][3]. The differentiation of naïve CD4+ T cells into Th2 cells is primarily driven by exposure to polarizing signals such as IL‑4 via STAT6/GATA3 transcriptional pathways[1][3]. "T helper type 2 cytokine production" describes a functional output or biological process rather than a discrete molecular target; therefore it is not considered a therapeutic target itself but rather an outcome modulated by targeting upstream molecules like the interleukin receptors or transcription factors involved in Th2 differentiation[1][3]. > *Note*: This entry does **not** refer to a specific molecule or receptor but instead describes an immunological function/process. For structured data purposes it should be flagged as incorrect for use as a canonical drug target name.

Other names

Th2 cytokine secretionType 2 helper T cell cytokine releaseTh2 response